Leaflet NITIZINONA MENDELIKABS 10mg capsules

Product code:
W64611001
Quantity:
60
Indicated for:
hereditary tyrosinemia type 1
Route of administration:
oral
Substance:
nitisinone (enzyme inhibitor)
ATC
A16AX04 — Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products
Nitisinone is a medication used for the treatment of hereditary tyrosinemia type 1, a rare metabolic disorder caused by an enzymatic deficiency. It works by inhibiting an enzyme involved in tyrosine metabolism, preventing the accumulation of toxic metabolites in the body.

The medication is taken orally, usually once or twice daily, with the dose adjusted based on the patient's weight and plasma tyrosine levels. Common side effects include elevated tyrosine levels, photosensitivity, and eye irritation.

Nitisinone is contraindicated in patients with hypersensitivity to the active substance. Additionally, it is important for patients to follow a strict low-tyrosine and low-phenylalanine diet to maximize the treatment's effectiveness.

This medication is an essential option for managing type 1 tyrosinemia, preventing severe complications and improving the quality of life for affected patients.

General data about NITIZINONA MENDELIKABS 10mg

Substance:
nitisinone
Date of latest medicines list:
01-08-2018
Product code:
W64611001
Concentration:
10mg
Pharmaceutical form:
capsules
Quantity:
60
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for nitisinone

  • 10mg
  • 2mg
  • 5mg